Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed...Research Collaboration and Funding Agreement • May 6th, 2015 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • Pennsylvania
This Research Collaboration and Funding Agreement (this “Agreement”), is entered into by and between OnCore Biopharma, Inc., a Delaware corporation (“Company”), and the Baruch S. Blumberg Institute, a Pennsylvania not-for-profit company (“Institution”), as of October 29, 2014 (the “Effective Date”).
Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed...Research Collaboration and Funding Agreement • August 4th, 2016 • Arbutus Biopharma Corp • Pharmaceutical preparations • Pennsylvania
This Amended and Restated Research Collaboration and Funding Agreement (this “Agreement”), is entered into by and between Arbutus Biopharma, Inc., a Delaware corporation (“Company”), and the Baruch S. Blumberg Institute, a Pennsylvania not-for-profit company (“Institution”), as of June 5, 2016 (the “Effective Date”). Each of Company and Institution may be referred to herein individually as a “Party” and jointly as the “Parties”.
